Covid-19: version of the Moderna vaccine aimed at Omicron approved in the UK

The British medicines regulator announced on Monday that it has approved a new generation of Moderna’s Covid-19 vaccine targeting the Omicron variant, a world first according to the laboratory.

This version of the vaccine consists of a booster dose targeting half the original virus strain and half the Omicron variant and “elicits a strong immune response” against both, including the Omicron BA.4 and BA.5 subvariants. , with “low” side effects similar to those seen with the original serums, the Medicines and Healthcare Products Regulatory Agency (MHRA) said in a statement.

>> More info to come at BFMTV.com